Processa Pharmaceuticals, Inc. (Nasdaq: PCSA), a clinical-stage biopharmaceutical company developing Next Generation Cancer ...

Nuvectis Pharma, Inc. (NASDAQ: NVCT), a clinical stage biopharmaceutical company focused on the development of innovative precision medicines for the treatment of serious conditions of unmet medical ...

Poster applications for the 2025 Office of Interdisciplinary Graduate Program's (OIGP) Spring Reception are now closed. Our reception will take place in-person this year on May 7th, 2025 from 9:30 a.m ...

VENTURE Study Exploratory Analysis Shows VK2735 Improved Cardiometabolic Parameters After 13 Weeks; Reducing Prediabetes and Metabolic Syndrome SAN DIEGO, Nov. 6, 2025 /PRNewswire/ -- Viking ...

Syndax’s leadership in menin inhibition and CSF-1R inhibition – – Revumenib abstracts showcase compelling results in multiple acute leukemia subtypes across the R/R, frontline, and post-HSCT setting – ...

Incyte (Nasdaq:INCY) today announced that data from key programs in its oncology portfolio will be presented in both oral and poster sessions at the 2025 American Society of Hematology (ASH) Annual ...

LA CROSSE, Wis. (WKBT) -- Viterbo University welcomed undergraduate researchers from seven campuses Friday for the Seven ...

Other CIBMTR presentations will include additional results from ACCESS study; a trial in progress update on the ACCELERATE trial (NCT06859424), a platform protocol for testing multiple PTCy-based ...

The poster will be made available on the Presentations & Research page of Unicycive’s website following the poster ...

Since the end of summer, Aura Figueroa Gonzalez had been looking forward to this year's Student Research Symposium. A fourth-year Ph.D. candidate on Mayo Clinic's Florida campus, she was excited to ...

A recording of this presentation will be made available on the company website. In addition, Biodesix executives, scientists, and expert consultants will be present at booth #647 to discuss Biodesix ...

Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based company with a well-established clinical diagnostic business and a therapeutic development business, today ...